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Abstract
Background: Many tobacco dependent cancer survivors continue to smoke after diagnosis and 
treatment. This study investigated the extent to which hospital-based cancer registries could be 
used to identify smokers in order to offer them assistance in quitting. The concordance of tobacco 
use coded in the registry was compared with tobacco use as coded in the accompanying Electronic 
Health Records (EHRs).
Methods: We gathered data from three hospital-based cancer registries in New York City during 
June 2014 to December 2016. For each patient identified as a current combustible tobacco user in 
the cancer registries, we abstracted tobacco use data from their EHR to independently code and 
corroborate smoking status. We calculated the proportion of current smokers, former smokers, and 
never smokers as indicated in the EHR for the hospitals, cancer site, cancer stage, and sex. We 
used a logistic regression model to estimate the log odds of the registry-based smoking status 
correctly predicting the EHR-based smoking status.
Results: Agreement in current smoking status between the registry-based smoking status and the 
EHR-based smoking status was 65%, 71%, and 90% at the three participating hospitals. Logistic 
regression results indicated that agreement in smoking status between the registry and the EHRs 
varied by hospital, cancer type, and stage, but not by age and sex.
Conclusions: The utility of using tobacco use data in cancer registries for population-based 
tobacco treatment interventions is dependent on multiple factors including accurate entry into 
EHR systems, updated data, and consistent smoking status definitions and registry coding 
protocols. Our study found that accuracy varied across the three hospitals and may not be able to 
inform interventions at these hospitals at this time. Several changes may be needed to improve the 
coding of tobacco use status in EHRs and registries.
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Introduction
Tobacco use is the leading preventable cause of illness and death in the United States.1,2 
Smoking cessation even after cancer diagnosis has many benefits including improving 
efficacy of cancer treatments, reducing treatment- and cancer-related symptoms, and 
reducing the impact of other diseases.3–7 Cancer survivors who quit smoking experience 
lower risks of dying from their cancer or of developing subsequent cancers compared with 
those who continue to smoke.2 However, many cancer survivors continue to smoke, and 
promoting smoking cessation among cancer survivors is well-established as an indicator of 
quality cancer care.8
Beyond medical-legal requirements, electronic health records (EHRs) provide opportunities 
to enhance patient care, embed performance measures in clinical practice and facilitate 
clinical research through identification of patients who might benefit from and be eligible 
for behavioral and biomedical intervention trials. Identifying cohorts of at-risk patients and 
creating patient registries with linkage to patient contact information readily enables real-
time targeting of evidence-based cancer prevention and control interventions.9 Databases for 
identifying at-risk populations and delivering population-based interventions include 
electronic patient registries (e.g., cancer registries) and EHRs, which allow for real-time 
access to health data and patient contact information.9 The use of EHRs to guide and deliver 
population-based interventions, however, can be challenging because of the variety of EHR 
platforms as well as lack of interoperability, accuracy, and harmonization of patient data. For 
example, proactive tobacco use treatment approaches that identify current tobacco users and 
directly offer treatment for tobacco dependence have been shown to increase the use of 
tobacco use treatment and long-term abstinence in primary care and mental health 
populations.10,11 The use of registries and EHRs to guide and deliver population-based 
interventions can be challenging because of the variety of electronic platforms available, as 
well as inconsistency in registry or EHR implementation, even when using the same 
platform.
The Health Information Technology for Economic and Clinical Health (HITECH) Act,12 the 
Patient Protection and Affordable Care Act (ACA) and the U.S. Public Health Service have 
provided guidelines to systematically collect data on key clinical outcomes, with the ACA 
enabling financial incentives for health care providers to ask patients about tobacco use 
during clinical encounters and document patient responses in the EHR. For instance, 
HITECH7 has a recommended EHR outline for capturing tobacco use organized into five 
categories: history, assessment,13 plan (quit date/counseling), pharmacotherapy, and a follow 
up plan. Since these categories are not mandatory fields in the recommended EHR outline 
and may be overlooked by providers, the frequency and quality of the data gathering are 
unknown.9 Some investigations have begun to examine the effect of variation in EHR 
platform use and patient outcomes.9,14 For example, Bae and colleagues reviewed the effects 
of using basic and advanced EHRs to document smoking status, delivery of smoking 
cessation counseling, and smoking cessation medication recommendations.9 They concluded 
that “more sophisticated EHRs are associated with better smoking cessation support by 
physicians.”9 Additionally, they recognized the need for an analysis of EHR platforms and 
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functions and that future meaningful use incentive programs need explicit coding for 
documentation of tobacco use and follow ups.9
While all states and the District of Columbia have central cancer registries (to which 
hospital-based cancer registries and other health care facilities send data on cancer diagnoses 
and related variables), tobacco use variables are not currently required by the North 
American Association of Central Cancer Registries to be collected.15 Some central cancer 
registries have continued to collect tobacco use variables, but not in a standardized format. A 
recent assessment of tobacco use data collected from 10 National Program of Cancer 
Registries (NPCR) registries funded for an enhanced data collection project concluded that 
“studies to evaluate the validity of specific tobacco‐related variables and the ability of cancer 
registries to capture this information from the medical record are needed.”16 Addressing 
barriers for this identification and accurate documentation of tobacco use in the EHR is 
essential because proactive tobacco dependence treatment approaches that identify smokers 
and directly offer them cessation treatment for tobacco use have been shown to increase its 
use and long-term abstinence in primary care and mental health populations.16
This study draws from the preliminary work done in preparation for a tobacco dependence 
treatment clinical trial, the aim of which was to assess the feasibility and effectiveness of 
using hospital cancer registry-based tobacco use status to identify and offer tobacco 
cessation treatment to smokers with a recent diagnosis of cancer. The sampling and 
recruitment plan called for use of hospital cancer registry data to identify a cohort of eligible 
tobacco dependent cancer survivors. The current study has two primary aims: 1) to describe 
how the EHRs used at three large cancer care settings and corresponding cancer registries 
coded for tobacco use status, and 2) to compare and examine extent of agreement of tobacco 
use data coded in the cancer registries to that coded in the patient’s EHR.
Methods
Study population.
We worked with cancer registry programmers at three hospital-based cancer treatment 
settings in New York City (described below) to identify our study sample using cancer 
staging, administrative, and treatment date codes contained in the cancer registry. These 
study locations were chosen as they have affiliations with the primary project location (New 
York University Langone Health). The locations encompassed a National Cancer Institute 
designated comprehensive cancer center (New York University Perlmutter Cancer Center), 
Bellevue Hospital, the flagship public hospital in New York City, and the VA New York 
Harbor, the Veterans Administration hospital encompassing Manhattan and Brooklyn. Each 
hospital system used different EHR systems and maintains their own independent cancer 
registry. Eligibility requirements were: a) currently smoked a tobacco product in the past 30 
days. b) any cancer diagnosis of less than stage 3B in the previous two years (June 2014 to 
December 2016) and c) no diagnosis of dementia. We used pathological staging codes as the 
primary source of staging data and used clinical staging codes when pathological staging 
was not available.17
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Tobacco use status from cancer registry.
We identified tobacco users using an administrative code for tobacco status available in the 
registry. Each case in the cancer registry was categorized using New York state-mandated 
codes: 1) never used, 2) current cigarette smoker, 3) current cigar/pipe smoker, 4) current 
snuff/chew/smokeless tobacco user, 5) mixed use, 6) former smoker, or 7) unknown. We 
selected all patients with codes 2, 3 or 5 as representing patients currently using combustible 
forms of tobacco. Non-combustible tobacco use (chewing tobacco, snuff or other smokeless 
tobacco) and former smoker were not a target of the cessation intervention and therefore 
were not included in the sampling plan. Use of electronic cigarettes also was not included.
Tobacco use abstraction from EHR.
For each patient identified as a current combustible tobacco smoker in the cancer registries, 
we abstracted tobacco use data from their EHR to independently code smoking status. Each 
hospital EHR documented tobacco use differently (see Table 1). The hospital that used the 
EPIC EHR system18 documented smoking status as a variable in the substance use history. 
This EHR platform enabled more granular fields to categorize patients as current every day 
smoker, current some day smoker, former smoker, heavy smoker, light smoker, never 
assessed, never smoker, passive smoke exposure- never smoker, smoker-current status 
unknown, and unknown if ever smoked. The VA and Bellevue clinics documented smoking 
status and history under social history in provider notes. While the VA creates tobacco use 
reminders that providers must complete every 6 months in the Computerized Patient Record 
System (CPRS) EHR, these data are not able to be seen by provider-users of the EHR and 
only available via a group data query. The Bellevue system (Misys) has neither clinical 
reminders nor tobacco use history available as a provider-facing variable. For all clinics, we 
reviewed provider notes within each patient’s EHR to confirm that the listed smoking status 
was accurate and updated. The most recent smoking status was used to code patients as 
never, former, or current smokers. When no smoking history information could be found, 
patients were coded as never smokers, consistent with registry practice. For current and 
former smokers, we extracted years of smoking and the most recent ‘cigarettes per day’ 
information when available. When ‘pack per day’ was used in a patient’s EHR instead of 
‘cigarettes per day’, we calculated ‘cigarettes per day’ based on a standard pack with 20 
cigarettes. We also included date of quitting for former smokers.
Data Analysis.
Descriptive statistics were calculated for each hospital to assess the number of current 
combustible tobacco users identified using the registry for all cancer patients diagnosed 
during 2014–2016, to determine the availability of detailed tobacco use data in the EHR for 
these patients, and to compare the coding of registry-based smoking status to that from the 
EHR. We calculated the proportion of current smokers, former smokers, and never smokers 
as indicated in the EHR for the hospitals, cancer site, cancer stage, and sex. We used a 
logistic regression model to estimate the log odds of the registry-based cigarette smoking 
status correctly predicting the EHR-based cigarette smoking status. The dependent variable 
in the model was an indicator of the prediction status; this indicator had a value of 1 if the 
smoking status in the EHR was “current smoker” and a value of 0 if the smoking status was 
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either “former smoker” or “never smoker”. The model adjusted for hospital, cancer site, 
cancer stage, sex, and age. We did not conduct sensitivity analyses as it was not feasible to 
check registry patients who did not have an indication of tobacco use against the EHRs. 
Analyses were conducted using R 3.4.3.19
Results
Current tobacco use (inclusive of cigarettes and cigar/pipe), at each of the three study 
locations using cancer registry data is reported in Table 2, and ranged from 6.3% at NYU, 
7.5% at Bellevue, and 19.1% at the VA.
As shown in Table 3, agreement in current cigarette smoking status between the registry-
based smoking status and the EHR-based cigarette smoking status ranged from 65% at the 
VA to 71% at NYU and 90% at Bellevue. About 25% of patients identified by the NYU and 
VA cancer registries as current smokers were classified by their EHRs as former smokers. A 
small fraction (4% to 9%) of patients identified as current smokers in the cancer registries 
were classified as never smokers in the EHRs. The overall positive predictive value 
aggregating across clinics was 72.2% (95% CI: 70.9%, 73.4%) (data not shown in table).
Logistic regression results indicated that agreement in cigarette smoking status between the 
registry and the EHR varied by hospital, cancer type, and stage, but not by age and sex 
(Table 4). Agreement in smoking status between the registry and the EHR was more likely at 
Bellevue than at NYU or the VA and among persons with endocrine (OR = 2.79, 95% CI: 
1.15–6.23), genitourinary (OR = 1.99, 95% CI: 1.20–3.29), and hematologic malignancies 
(OR = 2.10, 95% CI: 1.04–4.25) compared to those with lung cancer, as well as for those 
with stage I cancer compared to stage 0 (OR = 1.96, 95% CI: 1.07–3.58). Age was not 
associated with agreement in current cigarette smoking status (OR = 1.01, 95% CI: 1.00–
1.03). Classification accuracy did not differ by sex.
The Bellevue EHR had the least amount of data about cigarettes per day (32.1%) and years 
smoked (22.8%). NYU had data available for about half of their patients, while VA had 
cigarettes per day for 55% of patients, but we could not find years smoked for any of the 
registry-identified smokers.
Discussion
This is the first study to compare smoking status recorded in hospital cancer registries with 
that recorded in EHRs. Using tobacco use data recorded in cancer registries could be a 
potential way to identify cancer survivors who smoked at the time of diagnosis. However, 
because information about tobacco use in cancer registries has not been routinely collected, 
questions remain about the quality, validity, and usefulness of these data.
We found that while most patients classified as current smokers in the cancer registry were 
also classified as current smokers in the EHRs, about a quarter were classified as former 
smokers and a small fraction as never smokers. The largest discrepancies occurred when the 
registry categorizes patients as current smokers while the EHRs categorizes them as former 
smokers. Smoking status was abstracted from the EHR 6 to 24 months after it was recorded 
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in the cancer registry so it is possible that patients could have quit smoking during that 
interval. The discrepancies also could be due to differences in the way that the tobacco use 
questions were worded, differences in the way the patient responded to tobacco use 
questions, or differences in the way that responses were recorded.
Our study found that there was inconsistency in how tobacco use was recorded across three 
EHR systems. Only one EHR system (EPIC at NYU) included tobacco use as a user-facing 
variable; it also included the number of cigarettes smoked per day and the number of years 
smoked as variables. Thus, rates were highest for this information compared to Bellevue and 
the VA, which did not have variables for these details. The VA system prompts providers to 
assess tobacco use yearly, but does not allow users to see previous answers, and the Misys 
system at Bellevue had no tobacco prompts or standardized fields. In terms of agreement 
with registry data, agreement with current EHR information ranged from 65% to 90% for 
current cigarette use. Missing data rates for cigarettes per day and years smoked were high 
as systems did not have standardized or required fields for these data points.
Examining the EHR systems suggests reasons for such variability. Even though Bellevue 
Mysis did not have tobacco use prompts, the agreement between EHR and registry data was 
highest at 90%. This could be attributable to the fact that tobacco use data is recorded only 
in clinical notes, which are able to be viewed by the registry. The lowest rate of agreement 
was at the VA, which prompts for and records tobacco use, but does not allow this 
information to be seen by EHR users, including registry abstractors. Thus registry can only 
record it if providers describe tobacco use in a clinical note. NYU’s EPIC build makes 
tobacco use data available, but abstractors prioritize oncology notes over the Social History/
Smoking Status section, which is updated more frequently.
While this is the first study to compare EHR and cancer registry data, rates of recording 
smoking status in EHRs have been examined in previous studies, particularly in the lung 
cancer screening literature. A study of 4 lung cancer screening programs found that pack 
history and quit date could only be determined for 44% of those screened at one clinic and 
44% at another, leading to considerable uncertainty about screening eligibility.20 Another 
study found that EHRs underreported pack years in 85% of cases,21 and the VA lung cancer 
screening demonstration project found inaccurate pack years in 39% of patients.22 Another 
recent study surveyed 200 patients and compared survey data to EHR data for determining 
eligibility for lung cancer screening found that only 70% had complete data for smoking 
status, years smoked, and pack years, rates which were on par or higher than our best results, 
found in NYU’s EPIC system.23
In terms of limitations, we were not able to conduct a full sensitivity analysis. Our screening 
was for the purposes of enrollment for a smoking cessation clinical trial and we did not have 
resources to examine false negatives in the registry, that is, patients who were listed as non-
tobacco users in the registry but who were categorized as current smokers in the EHRs. Such 
data would help to elucidate the quality of registry coding for tobacco use. Additionally, 
sample sizes, and thus reliability of estimates differed across clinics. Nevertheless, our data 
provides valuable insights for evaluating the utility of registry data and for suggesting 
improvements related to tobacco use.
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A number of challenges exist in terms of ensuring accurate tobacco use coding and 
documentation in the EHR. First, no one health care provider or other staff may have sole 
workflow responsibility for entering tobacco use history, the format of questioning patients 
is not standardized across health systems and variations in categorizing tobacco use are not 
well-defined, which may lead to inaccurate data collection. For instance, asking someone 
“are you a smoker” rather than the recommended “have you used any tobacco product in the 
past 30 days” often resulted in a significantly different answer.24 Defining tobacco use 
behaviorally is essential as it prevents misinterpretation about non-frequent and light 
smoking and avoids using stigmatizing terms (i.e. “smoker”) which people are apt to deny. 
Moreover, misreporting of current smoking status may be attributable to the stigma 
associated with current smoking, particularly for cancer patients making it even more 
important to ask smoking status questions in an empathic and non-ambiguous manner. 
Second, the tobacco use categories and data entry fields are not standardized across EHR 
systems (e.g. “smoker” vs. “used tobacco product in past 30 days”), or do not exist as 
structured fields at all resulting in interoperability challenges. Third, delays from diagnosis 
to data coding into a registry has been noted as a barrier to using a registry for actionable 
decision making as patient smoking status can change during this time.25 Finally, without a 
defined field in an EHR for tobacco use, registry abstraction is difficult and left to each 
registrar to develop their own policy regarding where to look for tobacco use history data.
Improvements are needed at multiple levels from provider to EHR system design to increase 
data accuracy, perhaps the least burdensome for providers would be the patient updating 
social/medical history via an EHR-linked tablet prior to a visit. Such a system could readily 
adopt the recommendations of the National Cancer Institute-American Association for 
Cancer Research (NCI-AACR) Cancer Patient Tobacco Use Assessment Task Force, which 
has developed a systematic tobacco screening protocol, the Cancer Patient Tobacco Use 
Questionnaire (C-TUQ).24 While intended for clinical trials, the structure of the questions 
provides essential data to inform a full range of tobacco-related trials and clinical services 
including brief cessation counseling (e.g., Ask-Advise-Refer), population health 
interventions, and automated eligible case finding and clinical reminders for lung cancer 
screening.
EHRs offer the functionality for systematically assessing and documenting tobacco use, yet, 
as demonstrated by this study, problems remain in implementing reminders within the 
systems, quality of how tobacco use is assessed by the healthcare team, availability of 
tobacco use data, and comprehensiveness of the tobacco use history. These limitations may 
hamper the ability of health systems to support tobacco cessation efforts via direct care by 
healthcare providers as well as through use of proactive, population-based tobacco cessation 
programs.
Strategies are underway to improve screening and recording of tobacco use in EHRs that 
would lead to increased accuracy and usability for population health interventions, namely 
modifying the tobacco use screening process, and improved technologies. Raz et al found 
that improving the tobacco use screen was minimally burdensome and increased the quality 
of data.26 Another method for improving the quality of tobacco use data could be to institute 
technology-enabled survey devices that link to EHRs where patients can complete patient 
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reported outcomes and routine health update questions, including tobacco use history, prior 
to their appointments, thereby standardizing the questions and ensuring accurate data entry.
27
 While not widespread, some commercial systems are in place that allow patients to report 
data via tablet computer, and pilot studies have indicated acceptability on the part of patients 
and providers.28,29 Researchers have tried machine learning to search clinical notes with 
moderate success.30,31
Because tobacco use data collected by cancer registries is dependent on the documentation 
of tobacco use in the medical record, the quality of these data may benefit from improving 
provider training in assessing and documenting tobacco use in the EHR. Providing patients 
with a rationale for asking about tobacco use and discussing current tobacco use in an 
empathic manner is likely to improve accurate patient reporting.32 Documentation of 
tobacco use should be improved by educating health care providers about the importance 
and utility of tobacco use data and implementing organizational policies that encourage 
documenting tobacco use.
Tobacco use data in cancer registries is typically recorded at the time of diagnosis, and may 
not accurately reflect changes in tobacco status over the course of cancer treatment and 
survivorship. Our study results suggest registry-based tobacco use data does not appear to be 
sufficiently accurate at present to serve as a foundation for identifying eligible smokers for 
clinical trials and providing a referral to tobacco treatment services without greater attention 
to improving the quality of patient data capture. One has to consider available resources and 
weigh the benefits of offering cessation services to the cohort of current smokers versus 
reaching patients who may have stopped smoking (former smokers) since inclusion in the 
registry. For studies that need real-time tobacco status, registry-based tobacco status data 
may not be sufficient. However, registry-based tobacco status may be useful in examining 
the association between tobacco use at time of diagnosis and cancer outcomes and in making 
decisions about survivorship care.16 Efforts are needed to improve the accuracy of tobacco 
use screening and data capture protocols in EHRs. Registrars could also increase attention to 
accuracy of tobacco use coding, which can better inform proactive methods for providing 
smokers with treatment for tobacco dependence.
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Table 1.
Comparison of Tobacco Use Coding in 3 EHR Systems
Setting EHR 
System
Tobacco Use Coding Availability Clinical 
reminder?
New York 
University Langone 
Health
EPIC • current every day smoker
• current some day smoker
• former smoker
• heavy smoker
• light smoker
• never assessed, never smoker
• passive smoke exposure- never smoker
• smoker-current status unknown
• unknown if ever smoked
• Cigarettes per day
Variable. in Social 
History
Yes. On intake
Bellevue Mysis None Provider notes only No
VA New York 
Harbor
CPRS • Never
• Former
• Current
Variable, not user-
facing; Provider notes
Yes. Every 6 
months
Abbreviations: EHR: electronic health record
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Table 2:
Current tobacco use rates (determined from cancer registry) among cancer patients who met study eligibility 
criteria from 2014–2016 in three New York City hospitals and availability of detailed data in EHR for current 
tobacco users
Setting Patients
N
Current tobacco users*
N (%)
Data available for
cigarettes/day
N (%)
Data available for
years smoked
N (%)
New York University Langone Health 11,679 739 (6.3%) 422 (57.1%) 358 (48.4%)
Bellevue 1,461 109 (7.5%) 35 (32.1%) 27 (22.8%)
VA New York Harbor 839 160 (19.1%) 88 (55.0%) Not available
Abbreviations: EHR: electronic health record
*
Includes cigarettes and other tobacco use
J Registry Manag. Author manuscript; available in PMC 2020 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Krebs et al. Page 13
Table 3:
Smoking status abstracted from the EHR among patients identified as current cigarette users using cancer 
registry data from three New York City hospitals 2014–2016 by select characteristics.
Smoking Status in EHR
Smoker
N=687
Former Smoker
N=215
Never Smoker
N=50
Hospital
 NYU (n=696) 494 (71%)* 170 (24%) 32 (5%)
 Bellevue (n=108) 97 (90%)* 7 (6%) 4 (4%)
 VA (n= 148) 96 (65%)* 38 (26%) 14 (9%)
Cancer Site
 Respiratory/Thoracic 84 (66%) 40 (31%) 4 (3%)
 Head and Neck 21 (51%) 18 (44%) 2 (5%)
 Breast 98 (77%) 27 (21%) 2 (2%)
 Endocrine 49 (80%) 10 (16%) 2 (3%)
 Gastrointestinal 102 (73%) 28 (20%) 9 (6%)
 Genitourinary 159 (75%) 45 (21%) 9 (4%)
 Hematologic 68 (74%) 17 (18%) 7 (8%)
 Neurologic 43 (68%) 12 (19%) 8 (13%)
 Skin 52 (73%) 13 (18%) 6 (8%)
 Other 11 (65%) 5 (29%) 1 (6%)
Cancer Stage**
 0 43 (66%) 16 (25%) 6 (9%)
 I 237 (76%) 62 (20%) 13 (4%)
 II 140 (70%) 50 (25%) 9 (5%)
 III 74 (73%) 25 (25%) 3 (3%)
 IV 41 (63%) 19 (29%) 5 (8%)
 unstaged 152 (73%) 43 (21%) 14 (7%)
Sex
 Female 279 (76%) 78 (21%) 12 (3%)
 Male 408 (70%) 137 (23%) 38 (7%)
Abbreviations: EHR: electronic health record; NYU: New York University Langone Health; VA: VA New York Harbor
*
The percentage of patients identified as current smokers using cancer registry data and EHR (ie, agreement in current smoking status between the 
registry-based smoking status and the EHR-based smoking status).
**
Based on stage recorded in the EHR; cancers may have progressed from time of initial registry coding.
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Table 4:
Logistic regression model of the cancer registry-based smoking status correctly predicting the EHR-based 
smoking status among cancer patients in 3 New York City Hospitals, 2014-2016
OR 95% Lower Limit 95% Upper Limit
Hospital (vs. Bellevue)
 NYU 0.25 0.13 0.49***
 VA 0.19 0.09 0.41***
Cancer Site (vs. lung)
 Head and Neck 0.54 0.26 1.13
 Breast 1.88 0.99 3.55
 Endocrine 2.79 1.25 6.23*
 Gastrointestinal 1.58 0.91 2.73
 Genitourinary 1.99 1.20 3.29**
 Hematologic/Blood 2.10 1.04 4.25*
 Neurologic 1.48 0.70 3.12
 Skin 1.84 0.93 3.62
 Other 1.39 0.45 4.32
Cancer Stage (vs. 0)
 I 1.96 1.07 3.58*
 II 1.41 0.75 2.64
 III 1.76 0.85 3.63
 IV 0.91 0.40 2.06
 unstaged 1.61 0.83 3.14
Male (vs. Female) 0.77 0.53 1.11
Age (per year) 1.01 1.00 1.03
Abbreviations: EHR: electronic health record; NYU: New York University Langone Health; OR: Odds Ratio; VA: VA New York Harbor
***
= p < 0.001,
**
= p< 0.01,
*
= p > 0.05
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